# Clinical Study of Rituximab Combined With Corticosteroids or Rituximab Monotherapy in the Treatment of Primary Membranous Nephropathy

> **NCT05514015** · PHASE4 · RECRUITING · sponsor: **First Affiliated Hospital, Sun Yat-Sen University** · enrollment: 78 (estimated)

## Conditions studied

- Primary Membranous Nephropathy

## Interventions

- **DRUG:** rituximab combined with corticosteroids
- **DRUG:** rituximab

## Key facts

- **NCT ID:** NCT05514015
- **Lead sponsor:** First Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-29
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2024-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05514015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05514015, "Clinical Study of Rituximab Combined With Corticosteroids or Rituximab Monotherapy in the Treatment of Primary Membranous Nephropathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05514015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*